QuantiFERON-TB Gold Plus Test in Diagnostics of Latent Tuberculosis Infection in Children Aged 1–14 in a Country with a Low Tuberculosis Incidence

QuantiFERON-TB Gold Plus Test in Diagnostics of Latent Tuberculosis Infection in Children Aged 1–14 in a Country with a Low Tuberculosis Incidence

Bibliographic Details
Main Authors:	DAGMARA BORKOWSKA-TATAR, DAGMARA KRASIŃSKA, EWA AUGUSTYNOWICZ-KOPEĆ
Format:	Article
Language:	English
Published:	Sciendo 2021-05-01
Series:	Polish Journal of Microbiology
Subjects:	QuantiFERON-TB Gold Plus tuberculin skin test latent tuberculosis infection tuberculosis children
Online Access:	https://www.exeley.com/exeley/journals/polish_journal_of_microbiology/70/i_current/pdf/10.33073_pjm-2021-042.pdf

Similar Items

Evaluating the diagnostic accuracy of QIAreach QuantiFERON-TB compared to QuantiFERON-TB Gold Plus for tuberculosis: a systematic review and meta-analysis
by: Shima Mahmoudi, et al.
Published: (2024-06-01)

QuantiFERON® TB GOLD’ s applications in the tuberculosis disease
by: Maria Saladino, et al.
Published: (2014-06-01)

QuantiFERON-TB Gold and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Children
by: Hossein Masoumi Asl, et al.
Published: (2015-09-01)

Clinical utility of QuantiFERON TB Gold Test in the diagnosis of latent tuberculosis infections
by: Salvatore Nisticò, et al.
Published: (2010-03-01)

QuantiFERON-TB reversion in children and adolescents with tuberculosis
by: Paula Rodríguez-Molino, et al.
Published: (2024-03-01)

Comparative evaluation of QuantiFERON-TB gold in-tube plus for Mycobacterium tuberculosis infection among adolescents in China
by: Peng Lu, et al.
Published: (2025-02-01)

Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus
by: Elia Noemi Gallegos Morales, et al.
Published: (2017-05-01)

First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease
by: K. Fukushima, et al.
Published: (2022-01-01)

The Role of QuantiFERON-TB Gold Plus in Mycobacterium Tuberculosis Detection in a Severe HIV Immunocompromised Patient—Case Report
by: Florentina Dumitrescu, et al.
Published: (2021-11-01)

Evaluation of QuantiFERON-TB Gold for the Diagnosis of <i>Mycobacterium tuberculosis</i> Infection in HTLV-1-Infected Patients
by: Luana Leandro Gois, et al.
Published: (2024-11-01)

QuantiFERON® TB Gold IT in the diagnosis of active pulmonary TB
by: Clara Fabris, et al.
Published: (2010-03-01)

Evaluation of the performance of QuantiFERON®-TB Gold plus test in active tuberculosis patients
by: Cengiz Çavuşoğlu, et al.
Published: (2021-05-01)

Comparison of the tuberculin skin test and the QuantiFERON-TB Gold test in detecting latent tuberculosis in health care workers in Iran
by: Ehsan Mostafavi, et al.
Published: (2016-07-01)

Comparative Evaluation of Standard E TB-Feron ELISA and QuantiFERON-TB Gold Plus Assays in Patients with Tuberculosis and Healthcare Workers
by: In Young Yoo, et al.
Published: (2021-09-01)

Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
by: Khaled H. Mohamed, et al.
Published: (2012-07-01)

Diagnostic utility of QuantiFERON-TB gold (QFT-G) in active pulmonary tuberculosis
by: Ahmed Anwar, et al.
Published: (2015-01-01)

Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients
by: Sheng-Wei Pan, et al.
Published: (2023-10-01)

Comparison of the 2-step tuberculin skin test and QuantiFERON-TB Gold in-Tube test in the screening of latent tuberculosis infection in cancer patients
by: Hala A. Mohammad, et al.
Published: (2015-07-01)

QuantiFERON-TB Gold In-tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia
by: Selam Niguse, et al.
Published: (2018-05-01)

Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country
by: Sara Debulpaep, et al.
Published: (2019-07-01)

Comparison of QuantiFERON-TB gold in tube test versus tuberculin skin test for screening of latent tuberculosis infection in Saudi Arabia: A population-based study
by: Hanan H Balkhy, et al.
Published: (2016-01-01)

Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis
by: Yu Zhang, et al.
Published: (2023-01-01)

QuantiFERON-TB Gold In-Tube test in active tuberculosis patients and healthy adults
by: Benjawan Phetsuksiri, et al.
Published: (2018-10-01)

Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients
by: Ekrem Cengiz Seyhan, et al.
Published: (2016-01-01)

Risk factors for active tuberculosis in 938 QuantiFERON-positive schoolchildren in Mongolia: a community-based cross-sectional study
by: Davaasambuu Ganmaa, et al.
Published: (2019-06-01)

Utility of QuantiFERON TB gold test in a south Indian patient population of ocular inflammation
by: Babu Kalpana, et al.
Published: (2009-01-01)

QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG
by: Séverine Carrère-Kremer, et al.
Published: (2022-04-01)

The pros and cons of the QuantiFERON test for the diagnosis of tuberculosis, prediction of disease progression, and treatment monitoring
by: Elvis Ndukong Ndzi, et al.
Published: (2016-01-01)

Predictive metabolite signatures for risk of progression to active TB from QuantiFERON supernatants of household contacts of TB patients
by: Evangeline Ann Daniel, et al.
Published: (2025-12-01)

Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study
by: Nuntana Chumpa, et al.
Published: (2022-04-01)

Beyond QuantiFERON-TB Results, the Added Value of a Weak Mitogen Response
by: Marine Jacquier, et al.
Published: (2022-05-01)

Testing for Mycobacterium tuberculosis infection using the QuantiFERON-TB GOLD assay in patients with comorbid conditions in a tertiary care endemic setting
by: Kiran Iqbal Masood, et al.
Published: (2020-02-01)

Comparative study between using QuantiFERON and tuberculin skin test in diagnosis of Mycobacterium tuberculosis infection
by: Sohair A. Abdel-Samea, et al.
Published: (2013-01-01)

Comparison between Quanti-FERON-TB Gold In-Tube test and tuberculin skin test for diagnosis of latent tuberculosis in children: A cross-section study
by: Keyghobad Ghadiri, et al.
Published: (2020-01-01)

Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden
by: Thuli Mthiyane, et al.
Published: (2015-07-01)

Diagnostic utility of QuantiFERON-TB Gold and Xpert MTB/RIF combined with adenosine deaminase in tuberculous pleural effusion: a prospective study
by: Hassan Aref
Published: (2017-11-01)

Serial QuantiFERON-TB Gold In-Tube assay and tuberculin skin test to diagnose latent tuberculosis in household Mexican contacts: conversion and reversion rates and associated factors using conventional and borderline zone definitions
by: Joel Monárrez-Espino, et al.
Published: (2014-11-01)

Assessing the effects of diabetes mellitus on the monocyte-to-lymphocyte ratio and the QuantiFERON-TB gold plus assays for tuberculosis treatment monitoring: a prospective cohort study
by: Paulo Ranaivomanana, et al.
Published: (2025-01-01)

QuantiFERON-TB Gold plus testing for the detection of LTBI among health care workers in major TB hospitals of the Northern Kyrgyz Republic
by: Caroline Corbett, et al.
Published: (2022-02-01)

Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy
by: Chun-Yu Cheng, et al.
Published: (2015-09-01)